NCT07354087 2026-02-04
IMPACTEndoAsia
Tata Memorial Hospital
Active not recruiting
Clinical Trials
4 trialsNCT06790004 2025-06-12
LPSvsLPT
Azienda USL Reggio Emilia - IRCCS
Active not recruiting
NCT04122235 2025-01-03
LETSGO
Sorlandet Hospital HF
Phase NA Active not recruiting
NCT02521844 2024-10-08
A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours
EDDC (Experimental Drug Development Centre), A*STAR Research Entities
Phase 1 Active not recruiting